HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of intravenous immunoglobulin in treatment of acute retinal necrosis.

AbstractPURPOSE:
To describe a case of successful treatment of acute retinal necrosis with a combination of antivirals and intravenous immunoglobulin.
METHODS:
This is a case report of a 77-year-old white man diagnosed with unilateral acute retinal necrosis.
RESULTS:
Combination therapy with systemic antivirals, prophylactic laser retinopexy, and intravenous immunoglobulin halted progression of retinitis and preserved visual acuity.
CONCLUSION:
Acute retinal necrosis is an aggressive disease with significant risk of vision loss even when treated with appropriate therapy. In this report, the authors describe a case of successful treatment with a combination of systemic antivirals and intravenous immunoglobulin. Intraocular antiviral injection plus systemic treatment remain to be a more cost-effective option.
AuthorsGelareh Abedi, Manju L Subramanian, Edward Feinberg, Steven D Ness
JournalRetinal cases & brief reports (Retin Cases Brief Rep) Vol. 5 Issue 4 Pg. 363-5 ( 2011) ISSN: 1935-1089 [Print] United States
PMID25390437 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: